NSAIDs - Cardiovascular Risk Controversy | PPT
Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | SpringerLink
DICLOFENAC SODIUM
Eric Topol on X: "Bad news on diclofenac (Voltaren), a commonly used anti-inflammatory, with heart risks in excess of acetaminophen, naproxen and ibuprofen https://t.co/pXNzV5vCv4 @bmj_latest open-access by @Morten__Schmidt @ToftSorensen @Lars_HP ...
Chronic Use of NSAIDs for Chronic Pain
Diclofenac use and cardiovascular risks: series of nationwide cohort studies | The BMJ
Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction - ScienceDirect
Ibuprofen and cardiovascular safety
Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease | Circulation: Cardiovascular Quality and Outcomes
PDF) Diclofenac use and cardiovascular risks: Series of nationwide cohort studies
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis - Scholle - 2020 - Journal of Internal Medicine - Wiley Online Library
An Evidence-Based Review of the Cardiovascular Risks of Nonsteroidal Anti-Inflammatory Drugs - ScienceDirect
NSAIDs: Medicines involved | Medicines Safety Portal
NSAIDs and cardiovascular risk | Semantic Scholar
Diclofenac significantly increases cardiovascular risk, large study suggests | MIMS online
Use of Nonsteroidal Antiinflammatory Drugs | Circulation
Cardiovascular effects and safety of (non-aspirin) NSAIDs | Nature Reviews Cardiology
Diclofenac use and cardiovascular risks: series of nationwide cohort studies | The BMJ
Diclofenac (Voltaren) and risk of cardiovascular events (heart attack and stroke)
Diclofenac (Voltaren) and risk of cardiovascular events (heart attack and stroke)
